论文部分内容阅读
普洱天福经贸有限责任公司自1998年起开始对普洱茶的保健功效进行研究开发,迄今已有三项技术获得国家专利。其中,“抗HIV病毒,提高人体免疫力的保健普洱茶。专利号:ZL200810058022.8”引起了国内外的普遍关注。据介绍,普洱天福经贸有限公司自行研发的普洱茶,既有抗HIV活性,同时对合胞体抑制和MT-4细胞具有有效的保护作用,这在自然界单体植物中并不多见。经检测,天福公司专利技术生产的普洱茶,同时具有抑制HTV诱导合胞体形成作用以及保护HIV-1感染MIV-4死亡作用,其选择指数(治疗指数)TI值为32.55—48.70和4.68—6.84。是潜力极大的抗HIV活性产物的天然来源,具有很好的开发应用前景。
Pu’er Tianfu economic and trade limited liability company since 1998 began to study the health effects of Pu’er tea, so far have been three technology access to national patents. Among them, “anti-HIV virus, improve human immunity Pu’er tea patent number: ZL200810058022.8 ” has aroused widespread concern at home and abroad. According to reports, Pu’er Tianfu Economic and Trade Co., Ltd. Pu’er tea developed by itself, both anti-HIV activity, while syncytial inhibition and MT-4 cells have an effective protective effect, which is rare in the nature of monomer plants. Tested and tested by Tianfu Company’s patented technology, Pu’er tea also has the effect of inhibiting the formation of HTV-induced syncytia and protecting the death of MIV-4 infected with HIV-1. The TI values of selection index (therapeutic index) are 32.55-48.70 and 4.68-6.84 . It is a natural source of great potential anti-HIV active product and has good development and application prospects.